 President-elect Donald Trump speaks to the media after a meeting with Senate Majority Leader Mitch McConnell (R) at the Capitol. (Nicholas Kamm/AFP via Getty Images) By Carolyn Y. Johnson A single sentence in President-elect Donald Trump's health-care platform sends a strong hint to the drug and medical device industry that they may have an easier time getting their products on the market under his administration. "Reform the Food and Drug Administration, to put greater focus on the need of patients for new and innovative medical products," his health plan states. On the face of it, the bullet point may seem almost bland, but efforts to integrate patients' preferences and encourage innovation often result in proposals aimed at speeding up the process for getting new medicines on the market by easing regulations. Critics argue that such efforts can erode standards that are in place to protect patients from drugs that don't work and might even be harmful. Read the rest on Wonkblog.
Chart of the day The Mexican economy is particularly reliant on trade with the United States, which could give Donald Trump more leverage in negotiating a new trade deal. Ana Swanson has more. 
Top policy tweets | 
Twitter
Facebook
No comments:
Post a Comment